vs
Side-by-side financial comparison of Commercial Bancgroup, Inc. (CBK) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
Commercial Bancgroup, Inc. is the larger business by last-quarter revenue ($23.1M vs $18.9M, roughly 1.2× Electromed, Inc.). Commercial Bancgroup, Inc. runs the higher net margin — 41.3% vs 14.6%, a 26.7% gap on every dollar of revenue.
Commercial Bancgroup, Inc.CBKEarnings & Financial Report
Commercial Bancgroup, Inc. operates as a U.S. regional bank holding company that provides a full suite of retail and commercial banking products and services to individual consumers, small and medium-sized businesses, and local institutional clients. Its core offerings include deposit accounts, lending solutions, wealth management, and tailored financial advisory services for regional markets.
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
CBK vs ELMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $23.1M | $18.9M |
| Net Profit | $9.5M | $2.8M |
| Gross Margin | — | 78.4% |
| Operating Margin | — | 19.2% |
| Net Margin | 41.3% | 14.6% |
| Revenue YoY | — | 16.3% |
| Net Profit YoY | 9.7% | 40.3% |
| EPS (diluted) | $0.69 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $23.1M | — | ||
| Q4 25 | $23.5M | $18.9M | ||
| Q3 25 | $22.8M | $16.9M | ||
| Q2 25 | — | $17.4M | ||
| Q1 25 | — | $15.7M | ||
| Q4 24 | — | $16.3M | ||
| Q3 24 | — | $14.7M | ||
| Q2 24 | — | $14.8M |
| Q1 26 | $9.5M | — | ||
| Q4 25 | $9.9M | $2.8M | ||
| Q3 25 | $9.5M | $2.1M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $1.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 78.4% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | — | 76.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.2% | ||
| Q3 25 | 53.8% | 15.8% | ||
| Q2 25 | — | 17.5% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 15.6% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 15.7% |
| Q1 26 | 41.3% | — | ||
| Q4 25 | 42.2% | 14.6% | ||
| Q3 25 | 41.4% | 12.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 12.3% |
| Q1 26 | $0.69 | — | ||
| Q4 25 | $0.72 | $0.32 | ||
| Q3 25 | $0.77 | $0.25 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | — | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.8M |
| Total DebtLower is stronger | $118.2M | — |
| Stockholders' EquityBook value | — | $45.4M |
| Total Assets | $2.3B | $54.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $13.8M | ||
| Q3 25 | $154.8M | $14.1M | ||
| Q2 25 | — | $15.3M | ||
| Q1 25 | — | $15.2M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | — | $13.9M | ||
| Q2 24 | — | $16.1M |
| Q1 26 | $118.2M | — | ||
| Q4 25 | $166.8M | — | ||
| Q3 25 | $100.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $45.4M | ||
| Q3 25 | $245.2M | $44.7M | ||
| Q2 25 | — | $43.2M | ||
| Q1 25 | — | $43.9M | ||
| Q4 24 | — | $43.6M | ||
| Q3 24 | — | $41.5M | ||
| Q2 24 | — | $44.5M |
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | $54.9M | ||
| Q3 25 | $2.2B | $53.6M | ||
| Q2 25 | — | $53.8M | ||
| Q1 25 | — | $52.5M | ||
| Q4 24 | — | $52.3M | ||
| Q3 24 | — | $48.9M | ||
| Q2 24 | — | $52.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $3.0M |
| Free Cash FlowOCF − Capex | — | $2.4M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 3.4% |
| Cash ConversionOCF / Net Profit | — | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $3.0M | ||
| Q3 25 | $28.0M | $169.0K | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.4M | ||
| Q3 25 | $26.5M | $-83.0K | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.7% | ||
| Q3 25 | 115.8% | -0.5% | ||
| Q2 25 | — | 21.4% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 30.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.4% | ||
| Q3 25 | 6.7% | 1.5% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | 2.96× | 0.08× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | — | 1.60× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBK
| Net Interest Income | $20.5M | 89% |
| Noninterest Income | $2.6M | 11% |
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
